{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:31:06Z","timestamp":1787585466160,"version":"build-2736575974"},"reference-count":120,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health \u201cRicerca Corrente\u2013Linea 1\u2013INMI L. Spallanzani I.R.C.C.S.\u201d"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Togaviridae represents a candidate family for emerging public health emergencies of international concern. Among them, chikungunya virus (CHKIV) has caused recurrent epidemics in the temperate zone of most continents and represents a threat to the safety of blood supplies. The global expansion of vectors (i.e., Aedes mosquitoes) and increasing international travel have contributed to the growing epidemiological importance of this pathogen. In fact, CHIKV has been reported in more than 110 countries across the following four continents: Africa, Asia, Americas, and Europe. Consequently, public health authorities have emphasized the importance of surveillance, vector control programs, outbreak preparedness, and blood safety measures. The aim of this review was to summarize the current knowledge of CHIKV considering virology, molecular epidemiology, transmission mechanisms, clinical features, preventive strategies, and blood safety implications, with particular attention to issues relevant to transfusion services.<\/jats:p>","DOI":"10.3390\/v18080924","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:49:34Z","timestamp":1787582974000},"page":"924","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chikungunya Virus: What a Transfusion Service Needs to Know"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8811-195X","authenticated-orcid":false,"given":"Daniele","family":"Focosi","sequence":"first","affiliation":[{"name":"North-Western Tuscany Blood Bank, Pisa University Hospital, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0955-2074","authenticated-orcid":false,"given":"Giuseppe","family":"Sberna","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Laboratories of Biosecurity, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d\u2013IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0640-8667","authenticated-orcid":false,"given":"Francesca","family":"Colavita","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Laboratories of Biosecurity, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d\u2013IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7489-5271","authenticated-orcid":false,"given":"Fabrizio","family":"Maggi","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Laboratories of Biosecurity, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d\u2013IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Franchini","sequence":"additional","affiliation":[{"name":"Division of Hematology and Transfusion Medicine, \u201cCarlo Poma\u201d Hospital, 46100 Mantua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"ref_1","unstructured":"(2026, July 13). WHO Chikungunya. Available online: https:\/\/www.who.int\/health-topics\/chikungunya."},{"key":"ref_2","unstructured":"(2026, July 13). WHO Chikungunya Fact Sheet. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chikungunya."},{"key":"ref_3","unstructured":"(2026, July 13). WHO Chikungunya Virus Disease-Global Situation. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2025-DON581."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1099\/jgv.0.001072","article-title":"ICTV Report Consortium ICTV Virus Taxonomy Profile: Togaviridae","volume":"99","author":"Chen","year":"2018","journal-title":"J. Gen. Virol."},{"key":"ref_5","unstructured":"(2026, July 13). ICTV Genus: Alphavirus | ICTV. Available online: https:\/\/ictv.global\/report\/chapter\/togaviridae\/togaviridae\/alphavirus."},{"key":"ref_6","unstructured":"(2026, July 13). ECDC Chikungunya Virus Disease. Available online: https:\/\/www.ecdc.europa.eu\/en\/chikungunya-virus-disease."},{"key":"ref_7","unstructured":"(2026, July 13). ECDC Seasonal Surveillance for Chikungunya Virus Disease in the EU\/EEA for 2025. Available online: https:\/\/www.ecdc.europa.eu\/en\/chikungunya-virus-disease\/surveillance-and-updates\/seasonal-surveillance."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"10118","DOI":"10.1128\/JVI.75.21.10118-10131.2001","article-title":"Evolutionary Relationships and Systematics of the Alphaviruses","volume":"75","author":"Powers","year":"2001","journal-title":"J. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1146\/annurev-virology-091919-102021","article-title":"New Insights into Chikungunya Virus Infection and Pathogenesis","volume":"8","author":"Kril","year":"2021","journal-title":"Annu. Rev. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1038\/s41467-022-31835-x","article-title":"CHIKV Infection Reprograms Codon Optimality to Favor Viral RNA Translation by Altering the tRNA Epitranscriptome","volume":"13","author":"Jungfleisch","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1258\/td.2007.070019","article-title":"Chikungunya: A Review","volume":"38","author":"Jain","year":"2008","journal-title":"Trop. Doct."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1093\/infdis\/jiw391","article-title":"Chikungunya: Its History in Africa and Asia and Its Spread to New Regions in 2013\u20132014","volume":"214","author":"Zeller","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1128\/JVI.01603-09","article-title":"Genome-Scale Phylogenetic Analyses of Chikungunya Virus Reveal Independent Emergences of Recent Epidemics and Various Evolutionary Rates","volume":"84","author":"Volk","year":"2010","journal-title":"J. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev-ento-011019-025207","article-title":"Chikungunya Virus: Role of Vectors in Emergence from Enzootic Cycles","volume":"65","author":"Weaver","year":"2020","journal-title":"Annu. Rev. Entomol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Tsetsarkin, K.A., Vanlandingham, D.L., McGee, C.E., and Higgs, S. (2007). A Single Mutation in Chikungunya Virus Affects Vector Specificity and Epidemic Potential. PLoS Pathog., 3.","DOI":"10.1371\/journal.ppat.0030201"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1007\/s00705-014-2210-4","article-title":"Involvement of ATP Synthase \u03b2 Subunit in Chikungunya Virus Entry into Insect Cells","volume":"159","author":"Fongsaran","year":"2014","journal-title":"Arch. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jmv.23403","article-title":"Identification of Prohibitin as a Chikungunya Virus Receptor Protein","volume":"84","author":"Wintachai","year":"2012","journal-title":"J. Med. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Gardner, C.L., Hritz, J., Sun, C., Vanlandingham, D.L., Song, T.Y., Ghedin, E., Higgs, S., Klimstra, W.B., and Ryman, K.D. (2014). Deliberate Attenuation of Chikungunya Virus by Adaptation to Heparan Sulfate-Dependent Infectivity: A Model for Rational Arboviral Vaccine Design. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0002719"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1128\/JVI.03116-13","article-title":"A Single-Amino-Acid Polymorphism in Chikungunya Virus E2 Glycoprotein Influences Glycosaminoglycan Utilization","volume":"88","author":"Silva","year":"2014","journal-title":"J. Virol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"De Caluw\u00e9, L., Coppens, S., Vereecken, K., Daled, S., Dhaenens, M., Van Ostade, X., Deforce, D., Ari\u00ebn, K.K., and Bartholomeeusen, K. (2021). The CD147 Protein Complex Is Involved in Entry of Chikungunya Virus and Related Alphaviruses in Human Cells. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.615165"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41586-018-0121-3","article-title":"Mxra8 Is a Receptor for Multiple Arthritogenic Alphaviruses","volume":"557","author":"Zhang","year":"2018","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Jemielity, S., Wang, J.J., Chan, Y.K., Ahmed, A.A., Li, W., Monahan, S., Bu, X., Farzan, M., Freeman, G.J., and Umetsu, D.T. (2013). TIM-Family Proteins Promote Infection of Multiple Enveloped Viruses through Virion-Associated Phosphatidylserine. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003232"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrmicro3469","article-title":"Viral Apoptotic Mimicry","volume":"13","author":"Amara","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1128\/JVI.03184-15","article-title":"Dynamics of Chikungunya Virus Cell Entry Unraveled by Single-Virus Tracking in Living Cells","volume":"90","author":"Hoornweg","year":"2016","journal-title":"J. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Bernard, E., Solignat, M., Gay, B., Chazal, N., Higgs, S., Devaux, C., and Briant, L. (2010). Endocytosis of Chikungunya Virus into Mammalian Cells: Role of Clathrin and Early Endosomal Compartments. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0011479"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"101413","DOI":"10.1016\/j.onehlt.2026.101413","article-title":"Research Advances in Chikungunya Virus: Epidemiology, Pathogenesis, and Control","volume":"22","author":"Dai","year":"2026","journal-title":"One Health"},{"key":"ref_27","first-page":"e108409","article-title":"The Burden of Chikungunya in India: An Overview of Clinical, Epidemiological, and Public Health Challenges","volume":"18","author":"Patil","year":"2026","journal-title":"Cureus"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41572-023-00442-5","article-title":"Author Correction: Chikungunya Fever","volume":"9","author":"Bartholomeeusen","year":"2023","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Contopoulos-Ioannidis, D., Newman-Lindsay, S., Chow, C., and LaBeaud, A.D. (2018). Mother-to-Child Transmission of Chikungunya Virus: A Systematic Review and Meta-Analysis. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006510"},{"key":"ref_30","unstructured":"(2026, July 13). ECDC Factsheet for Health Professionals about Chikungunya Virus Disease. Available online: https:\/\/www.ecdc.europa.eu\/en\/chikungunya\/facts\/factsheet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4269\/ajtmh.15-0308","article-title":"Seroprevalence of Asian Lineage Chikungunya Virus Infection on Saint Martin Island, 7 Months After the 2013 Emergence","volume":"94","author":"Gay","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"G\u00e9rardin, P., Guernier, V., Perrau, J., Fianu, A., Le Roux, K., Grivard, P., Michault, A., De Lamballerie, X., Flahault, A., and Favier, F. (2008). Estimating Chikungunya Prevalence in La R\u00e9union Island Outbreak by Serosurveys: Two Methods for Two Critical Times of the Epidemic. BMC Infect. Dis., 8.","DOI":"10.1186\/1471-2334-8-99"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/trstmh\/trt083","article-title":"Risk Factors for Symptomatic and Asymptomatic Chikungunya Infection","volume":"107","author":"Nakkhara","year":"2013","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_34","unstructured":"(2026, July 13). CDC About Chikungunya Virus, Available online: https:\/\/www.cdc.gov\/chikungunya\/about\/index.html."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1016\/S1473-3099(16)30385-1","article-title":"Chikungunya Virus: An Update on the Biology and Pathogenesis of This Emerging Pathogen","volume":"17","author":"Burt","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/517537","article-title":"Outbreak of Chikungunya on Reunion Island: Early Clinical and Laboratory Features in 157 Adult Patients","volume":"44","author":"Borgherini","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11908-011-0180-1","article-title":"Chikungunya Virus Infection","volume":"13","author":"Simon","year":"2011","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Amaral, J.K., Taylor, P.C., Teixeira, M.M., Morrison, T.E.T., and Schoen, R.T. (2019). The Clinical Features, Pathogenesis and Methotrexate Therapy of Chronic Chikungunya Arthritis. Viruses, 11.","DOI":"10.3390\/v11030289"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/qjmed\/hcae028","article-title":"Chronic Chikungunya Disease (CCD): Clinical Insights, Immunopathogenesis and Therapeutic Perspectives","volume":"117","author":"Ng","year":"2024","journal-title":"QJM"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s12028-017-0413-8","article-title":"The Range of Neurological Complications in Chikungunya Fever","volume":"27","author":"Cerny","year":"2017","journal-title":"Neurocrit. Care"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41426-017-0010-0","article-title":"Broad and Long-Lasting Immune Protection against Various Chikungunya Genotypes Demonstrated by Participants in a Cross-Sectional Study in a Cambodian Rural Community","volume":"7","author":"Auerswald","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"S471","DOI":"10.1093\/infdis\/jiw274","article-title":"Laboratory Diagnosis of Chikungunya Virus Infections and Commercial Sources for Diagnostic Assays","volume":"214","author":"Johnson","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e00350-19","DOI":"10.1128\/JCM.00350-19","article-title":"Beyond Fever and Pain: Diagnostic Methods for Chikungunya Virus","volume":"57","author":"Natrajan","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"ref_44","unstructured":"Rodriguez-Morales, A.J. (2019). Diagnosis and Molecular Characterization of Chikungunya Virus Infections. Current Topics in Neglected Tropical Diseases, IntechOpen."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1111\/j.1537-2995.2012.03960.x","article-title":"Viremic Profiles in Asymptomatic and Symptomatic Chikungunya Fever: A Blood Transfusion Threat?","volume":"53","author":"Appassakij","year":"2013","journal-title":"Transfusion"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/834371","article-title":"Diagnostic Options and Challenges for Dengue and Chikungunya Viruses","volume":"2015","author":"Mardekian","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e00915-19","DOI":"10.1128\/mSphere.00915-19","article-title":"Robustness of Serologic Investigations for Chikungunya and Mayaro Viruses Following Coemergence","volume":"5","author":"Fischer","year":"2020","journal-title":"mSphere"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/vox.13707","article-title":"Urban Arbovirus Exposure in Blood Donations from an Endemic Area of Brazil","volume":"119","author":"Nunes","year":"2024","journal-title":"Vox Sang."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/trf.16110","article-title":"Detection of Dengue, Chikungunya, and Zika RNA in blood donors from Southeast Asia","volume":"61","author":"Stanley","year":"2021","journal-title":"Transfusion"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/CVI.00720-14","article-title":"Chikungunya Virus RNA and Antibody Testing at a National Reference Laboratory since the Emergence of Chikungunya Virus in the Americas","volume":"22","author":"Prince","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_51","unstructured":"(2026, July 31). Roche Roche Diagnostics. Available online: https:\/\/diagnostics.roche.com\/it\/it\/home.html."},{"key":"ref_52","unstructured":"(2026, July 31). Grifols Soluzioni Diagnostiche Grifols. Available online: https:\/\/www.diagnostic.grifols.com\/it\/home."},{"key":"ref_53","unstructured":"(2026, July 31). WHO Chikungunya\u2013Argentina. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/14-march-2016-chikungunya-argentina-en."},{"key":"ref_54","unstructured":"(2026, July 31). WHO Chikungunya\u2013Kenya. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/09-august-2016-chikungunya-kenya-en."},{"key":"ref_55","unstructured":"(2026, July 31). WHO Chikungunya\u2013United States of America. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/14-june-2016-chikungunya-usa-en."},{"key":"ref_56","unstructured":"(2026, July 31). WHO Chikungunya\u2013France. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/25-august-2017-chikungunya-france-en."},{"key":"ref_57","unstructured":"(2026, July 31). WHO Chikungunya\u2013Italy. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/29-september-2017-chikungunya-italy-en."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3201\/eid2401.171605","article-title":"Molecular Characterization of Autochthonous Chikungunya Cluster in Latium Region, Italy","volume":"24","author":"Bordi","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e01306-17","DOI":"10.1128\/genomeA.01306-17","article-title":"Full-Length Genome Sequence of a Chikungunya Virus Isolate from the 2017 Autochthonous Outbreak, Lazio Region, Italy","volume":"5","author":"Carletti","year":"2017","journal-title":"Genome Announc."},{"key":"ref_60","unstructured":"(2026, July 31). WHO Chikungunya\u2013Mombasa, Kenya. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/27-february-2018-chikungunya-kenya-en."},{"key":"ref_61","unstructured":"(2026, July 31). WHO Chikungunya\u2013Sudan. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/15-october-2018-chikungunya-sudan-en."},{"key":"ref_62","unstructured":"(2026, July 31). WHO Chikungunya\u2013Congo. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/01-may-2019-chikungunya-congo-en."},{"key":"ref_63","unstructured":"(2026, July 31). WHO Chikungunya\u2013Chad. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/chikungunya-chad."},{"key":"ref_64","unstructured":"(2026, July 31). WHO Geographical Expansion of Cases of Dengue and Chikungunya Beyond the Historical Areas of Transmission in the Region of the Americas. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2023-DON448."},{"key":"ref_65","unstructured":"(2026, July 31). WHO Chikungunya\u2013La R\u00e9union and Mayotte. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2025-DON567."},{"key":"ref_66","first-page":"101089","article-title":"Transfusion-Transmitted Infections: Risks and Mitigation Strategies for Oropouche Virus and Other Emerging Arboviruses in Latin America and the Caribbean","volume":"46","author":"Tabares","year":"2025","journal-title":"Lancet Reg. Health Am."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/trf.17921","article-title":"Evaluation of Assays for Nucleic Acid Testing for the Prevention of Chikungunya and Dengue Virus Transmission by Blood Transfusion","volume":"64","author":"Gallian","year":"2024","journal-title":"Transfusion"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/vox.12855","article-title":"Transfusion Risk Associated with Recent Arbovirus Outbreaks in French Polynesia","volume":"115","author":"Beau","year":"2020","journal-title":"Vox Sang."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/trf.12575","article-title":"The Risk of Blood Transfusion\u2013Associated C Hikungunya Fever during the 2009 Epidemic in S Ongkhla P Rovince, T Hailand","volume":"54","author":"Appassakij","year":"2014","journal-title":"Transfusion"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3201\/eid2108.150458","article-title":"Genomic Assays for Identification of Chikungunya Virus in Blood Donors, Puerto Rico, 2014","volume":"21","author":"Chiu","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3201\/eid2207.160116","article-title":"High Incidence of Chikungunya Virus and Frequency of Viremic Blood Donations during Epidemic, Puerto Rico, USA, 2014","volume":"22","author":"Simmons","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/tme.12855","article-title":"Chikungunya and Mayaro Infective Viruses in Components of Blood","volume":"32","author":"Thomazelli","year":"2022","journal-title":"Transfus. Med."},{"key":"ref_73","first-page":"267","article-title":"Prevalence of Chikungunya, Dengue and Zika Viruses in Blood Donors: A Systematic Literature Review and Meta-Analysis","volume":"20","author":"Arbona","year":"2022","journal-title":"Blood Transfus."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Gallian, P., Leparc-Goffart, I., Richard, P., Maire, F., Flusin, O., Djoudi, R., Chiaroni, J., Charrel, R., Tiberghien, P., and Lamballerie, X. (2017). Epidemiology of Chikungunya Virus Outbreaks in Guadeloupe and Martinique, 2014: An Observational Study in Volunteer Blood Donors. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005254"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1537-2995.2008.01646.x","article-title":"workgroup \u201cQuantitative Estimation of the Risk of Blood Donation Contamination by Infectious Agents\u201d Estimated Risk of Chikungunya Viremic Blood Donation during an Epidemic on Reunion Island in the Indian Ocean, 2005 to 2007","volume":"48","author":"Brouard","year":"2008","journal-title":"Transfusion"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Gim\u00e9nez-Richarte, \u00c1., Ortiz de Salazar, M.I., Gim\u00e9nez-Richarte, M.-P., Collado, M., Fern\u00e1ndez, P.L., Clavijo, C., Navarro, L., Arbona, C., Marco, P., and Ramos-Rincon, J.-M. (2022). Transfusion-Transmitted Arboviruses: Update and Systematic Review. PLoS Negl. Trop. Dis., 16.","DOI":"10.1371\/journal.pntd.0010843"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/infdis\/122.6.523","article-title":"Stabilization of Chikungunya Virus Infectivity by Human Blood Platelets","volume":"122","author":"Wheelock","year":"1970","journal-title":"J. Infect. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1139\/m77-185","article-title":"Contrasting Effects of Rabbit and Human Platelets on Chikungunya Virus Infectivity","volume":"23","author":"Chernesky","year":"1977","journal-title":"Can. J. Microbiol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Yue, C., Teitz, S., Miyabashi, T., Boller, K., Lewis-Ximenez, L.L., Baylis, S.A., and Bl\u00fcmel, J. (2019). Inactivation and Removal of Chikungunya Virus and Mayaro Virus from Plasma-Derived Medicinal Products. Viruses, 11.","DOI":"10.3390\/v11030234"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tmrv.2019.06.002","article-title":"The Potential Impact of Chikungunya Virus Outbreaks on Blood Transfusion","volume":"34","author":"Appassakij","year":"2020","journal-title":"Transfus. Med. Rev."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Mapako, T., Oei, W., van Hulst, M., Kretzschmar, M.E., and Janssen, M.P. (2016). Modelling the Risk of Transfusion Transmission from Travelling Donors. BMC Infect. Dis., 16.","DOI":"10.1186\/s12879-016-1452-z"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1111\/trf.14892","article-title":"Emergency Response of Four Transfusion Centers during the Last Chikungunya Outbreak in Italy","volume":"58","author":"Pierelli","year":"2018","journal-title":"Transfusion"},{"key":"ref_83","unstructured":"(2026, July 31). Roche Cobas\u00ae CHIKV\/DENV. Available online: https:\/\/diagnostics.roche.com\/it\/it\/products\/lab\/cobas-chikv-denv-6800-8800-pid00000368.html."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/trf.15128","article-title":"Duplex Nucleic Acid Test for the Detection of Chikungunya and Dengue RNA Viruses in Blood Donations","volume":"59","author":"Stramer","year":"2019","journal-title":"Transfusion"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/tmi.13863","article-title":"Pathogen Inactivation Methods to Prevent Transfusion-transmissible Arboviruses: A Systematic Review and Meta-analysis","volume":"28","author":"Larrea","year":"2023","journal-title":"Trop. Med. Int. Health"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1111\/trf.13729","article-title":"Dengue and Chikungunya Viruses in Plasma Are Effectively Inactivated after Treatment with Methylene Blue and Visible Light","volume":"56","author":"Fryk","year":"2016","journal-title":"Transfusion"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/trf.13519","article-title":"Inactivation of Dengue, Chikungunya, and Ross River Viruses in Platelet Concentrates after Treatment with Ultraviolet C Light","volume":"56","author":"Faddy","year":"2016","journal-title":"Transfusion"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.4269\/ajtmh.12-0603","article-title":"Photochemical Inactivation of Chikungunya Virus in Human Apheresis Platelet Components by Amotosalen and UVA Light","volume":"88","author":"Tsetsarkin","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1537-2995.2012.03717.x","article-title":"Photochemical Inactivation of Chikungunya Virus in Plasma and Platelets Using the Mirasol Pathogen Reduction Technology System","volume":"53","author":"Vanlandingham","year":"2013","journal-title":"Transfusion"},{"key":"ref_90","first-page":"1","article-title":"Evaluation of Pathogen Reduction Systems to Inactivate Dengue and Chikungunya Viruses in Apheresis Platelets Suspended in Plasma","volume":"03","author":"Tan","year":"2013","journal-title":"Adv. Infect. Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/vox.12626","article-title":"Amustaline (S-303) Treatment Inactivates High Levels of Chikungunya Virus in Red-blood-cell Components","volume":"113","author":"Aubry","year":"2018","journal-title":"Vox Sang."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/trf.14442","article-title":"Inactivation of Chikungunya Virus in Blood Components Treated with Amotosalen\/Ultraviolet A Light or Amustaline\/Glutathione","volume":"58","author":"Laughhunn","year":"2018","journal-title":"Transfusion"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/bjh.16093","article-title":"The Long and Winding Road to Pathogen Reduction of Platelets, Red Blood Cells and Whole Blood","volume":"186","author":"Rebulla","year":"2019","journal-title":"Br. J. Haematol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Melemenidis, S., Nguyen, K.D., Baraceros-Pineda, R., Barclay, C.K., Bautista, J., Lau, H.D., Ashraf, M.R., Manjappa, R., Dutt, S., and Soto, L.A. (2025). Rapid Sterilization of Clinical Apheresis Blood Products Using Ultra-High Dose Rate Radiation. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26062424"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"100173","DOI":"10.59717\/j.xinn-med.2025.100173","article-title":"Current Landscape with an Analytical Outlook: Chikungunya Virus Vaccine Development","volume":"3","author":"Zhao","year":"2025","journal-title":"TIME"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Heise, M. (2022). Chikungunya Virus Vaccines: Platforms, Progress, and Challenges. Chikungunya Virus, Springer International Publishing.","DOI":"10.1007\/978-3-030-90610-8"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.2147\/DDDT.S366112","article-title":"Chikungunya Vaccine Candidates: Current Landscape and Future Prospects","volume":"16","author":"Schmidt","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"ofaf695.408","DOI":"10.1093\/ofid\/ofaf695.408","article-title":"P-185. Safety, Efficacy and Immunogenicity of Chikungunya Vaccines: A Living Systematic Review and Meta-Analysis","volume":"13","author":"Sambade","year":"2026","journal-title":"Open Forum Infect. Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2469653","DOI":"10.1080\/22221751.2025.2469653","article-title":"Cross-Neutralizing Activity of the Chikungunya Vaccine VLA1553 against Three Prevalent Chikungunya Lineages","volume":"14","author":"Kosulin","year":"2025","journal-title":"Emerg. Microbes Infect."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/infdis\/jiw431","article-title":"A Virus-Like Particle Vaccine Elicits Broad Neutralizing Antibody Responses in Humans to All Chikungunya Virus Genotypes","volume":"214","author":"Goo","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s40259-024-00677-y","article-title":"Chikungunya Virus Vaccines: A Review of IXCHIQ and PXVX0317 from Pre-Clinical Evaluation to Licensure","volume":"38","author":"Weber","year":"2024","journal-title":"BioDrugs"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1128\/JVI.03453-13","article-title":"Novel Attenuated Chikungunya Vaccine Candidates Elicit Protective Immunity in C57BL\/6 Mice","volume":"88","author":"Kakoulidou","year":"2014","journal-title":"J. Virol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(23)00641-4","article-title":"Safety and Immunogenicity of a Single-Shot Live-Attenuated Chikungunya Vaccine: A Double-Blind, Multicentre, Randomised, Placebo-Controlled, Phase 3 Trial","volume":"401","author":"Schneider","year":"2023","journal-title":"Lancet"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e160173","DOI":"10.1172\/jci.insight.160173","article-title":"Effectiveness of CHIKV Vaccine VLA1553 Demonstrated by Passive Transfer of Human Sera","volume":"7","author":"Roques","year":"2022","journal-title":"JCI Insight"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijid.2020.03.073","article-title":"Pre-Existing Chikungunya Virus Neutralizing Antibodies Correlate with Risk of Symptomatic Infection and Subclinical Seroconversion in a Philippine Cohort","volume":"95","author":"Yoon","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00277-007-0413-4","article-title":"False Positive PET Scanning Caused by Inactivated Influenza Virus Vaccination during Complete Remission from Anaplastic T-Cell Lymphoma","volume":"87","author":"Focosi","year":"2008","journal-title":"Ann. Hematol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0140-6736(25)00345-9","article-title":"Chikungunya Virus Virus-like Particle Vaccine Safety and Immunogenicity in Adolescents and Adults in the USA: A Phase 3, Randomised, Double-Blind, Placebo-Controlled Trial","volume":"405","author":"Richardson","year":"2025","journal-title":"Lancet"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1111\/j.1537-2995.2009.02279.x","article-title":"Emerging Infectious Disease Agents and Their Potential Threat to Transfusion Safety","volume":"49","author":"Stramer","year":"2009","journal-title":"Transfusion"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1056\/NEJMe058144","article-title":"Problem Solved? West Nile Virus and Transfusion Safety","volume":"353","author":"Petersen","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"McCullough, J. (2021). Transfusion-Transmitted Diseases. Transfusion Medicine, Wiley.","DOI":"10.1002\/9781119599586"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"702","DOI":"10.5858\/2007-131-702-CROTAA","article-title":"Current Risks of Transfusion-Transmitted Agents: A Review","volume":"131","author":"Stramer","year":"2007","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1423-0410.2009.01286.x","article-title":"Transfusion-Transmitted Arboviruses","volume":"98","author":"Petersen","year":"2010","journal-title":"Vox Sang."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Cardoso, M., Ragan, I., Hartson, L., and Goodrich, R.P. (2023). Emerging Pathogen Threats in Transfusion Medicine: Improving Safety and Confidence with Pathogen Reduction Technologies. Pathogens, 12.","DOI":"10.3390\/pathogens12070911"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"357","DOI":"10.46234\/ccdcw2025.058","article-title":"Two-Year Surveillance of Dengue, Zika, and Chikungunya Viruses Among Chinese Blood Donors\u2014Guangxi and Yunnan PLADs, China, 2022\u20132023","volume":"7","author":"Yan","year":"2025","journal-title":"China CDC Wkly."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.antiviral.2009.10.008","article-title":"Present and Future Arboviral Threats","volume":"85","author":"Weaver","year":"2010","journal-title":"Antivir. Res."},{"key":"ref_116","unstructured":"(2026, July 13). EMA EMA Starts Review of Ixchiq (Live Attenuated Chikungunya Vaccine), Available online: https:\/\/www.aifa.gov.it\/en\/-\/ema-ha-avviato-un-riesame-di-ixchiq-vaccino-vivo-attenuato-contro-la-chikungunya-.-il-vaccino-non-%C3%A8-disponibile-in-italia."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"taad156","DOI":"10.1093\/jtm\/taad156","article-title":"A Randomized, Double-Blinded Phase 3 Study to Demonstrate Lot-to-Lot Consistency and to Confirm Immunogenicity and Safety of the Live-Attenuated Chikungunya Virus Vaccine Candidate VLA1553 in Healthy Adults","volume":"31","author":"McMahon","year":"2024","journal-title":"J. Travel Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e83527","DOI":"10.1172\/jci.insight.83527","article-title":"Attenuated and Vectored Vaccines Protect Nonhuman Primates against Chikungunya Virus","volume":"2","author":"Roques","year":"2017","journal-title":"JCI Insight"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S1473-3099(20)30238-3","article-title":"Single-Shot Live-Attenuated Chikungunya Vaccine in Healthy Adults: A Phase 1, Randomised Controlled Trial","volume":"20","author":"Wressnigg","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_120","unstructured":"(2026, July 13). ECDC Public Health Guidance for Assessing and Mitigating the Risk of Locally-Acquired Aedes-Borne Viral Diseases in the EU\/EEA. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/public-health-guidance-assessing-and-mitigating-risk-locally-acquired-aedes-borne."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/8\/924\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:54:39Z","timestamp":1787583279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/8\/924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":120,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["v18080924"],"URL":"https:\/\/doi.org\/10.3390\/v18080924","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]}}}